ArticleFrontiers in oncology2025

DLX2 promotes gastric cancer epithelial- mesenchymal transition and malignant progression through the PI3K/AKT signaling pathway.

Wenjing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.